Newcomers Undercut Price of BRCA Test; Myriad Lawsuits Claim Patent Infringement
Van Etten To Take Over As Director Of UC Irvine Chao Cancer Center
R01 and P01 Grants Will No Longer Support Phase III Clinical Trials
House Committee Seeks Review Of Indirect Costs Of NIH Grantees
Montana Drug Salesman Pleads Guilty to Selling Counterfeit Avastin
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation